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Background: Approximately 20% of patients are not satisfied with the outcome of total knee replacement, great
volumes of which are carried out yearly. Physiotherapy is often provided by the NHS to address dysfunction
following knee replacement; however the efficacy of this is unknown. Although clinically it is accepted that
therapy is useful, provision of physiotherapy to all patients post-operatively does not enhance outcomes at one
year. No study has previously assessed the effect of targeting therapy to individuals struggling to recover in the
early post-operative phase.
The aim of the TRIO study is to determine whether stratifying care by targeting physiotherapy to those individuals
performing poorly following knee replacement is effective in improving the one year outcomes. We are also
investigating whether the structure of the physiotherapy provision itself influences outcomes.
Methods/Design: The study is a multi-centre prospective randomised controlled trial (RCT) of patients undergoing
primary total knee replacement, with treatment targeted at those deemed most susceptible to gain from it. Use
of the national PROMS programme for pre-operative data collection allows us to screen all patients at initial
post-operative clinical review, and recruit only those deemed to be recovering slowly.
We aim to recruit 440 patients through various NHS orthopaedic centres who will undergo six weeks of
physiotherapy. The intervention will be either ‘intensive’ involving both hospital and home-based functional
exercise rehabilitation, or ‘standard of care’ consisting of home exercises. Patients will be randomised to either
group using a web-based system. Both groups will receive pre and post-intervention physiotherapy review.
Patients will be followed-up to one year post-operation. The primary outcome measure is the Oxford Knee Score.
Secondary outcomes are patient satisfaction, functional ability, pain scores and cost-effectiveness.
Trial registration: Current Controlled Trials ISRCTN23357609.
ClinicalTrials.gov NCT01849445.
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Knee osteoarthritis is an extremely common and extre-
mely disabling condition, often ultimately requiring surgi-
cal intervention. Total knee replacement (TKR) is an
increasingly common procedure with over 75,000 knee
replacements performed each year in the UK alone [1].
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stated.increases year on year [2]. TKR is highly effective at redu-
cing pain and improving physical function in patients with
end stage osteoarthritis. Around 20% of patients however
report dissatisfaction with their post-operative outcome,
twice the rate following total hip replacement [3-6].
Physiotherapy is a commonly employed intervention
to address dysfunction following TKR; though the efficacy
of this is unknown. A previous study suggested that post-
operative physiotherapy was not effective at improving the
patients’ one year outcome, when applied uniformly to allal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
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performing poorly post-operatively are often referred for
physiotherapy review; however no study has specifically
assessed patients that perform poorly post-operatively.
Demonstration of the effectiveness of post-operative phy-
siotherapy management in this ‘at risk’ group would
provide support for specific policy to address this
substantial population.
A recent Cochrane review examined multidisciplinary
rehabilitation programmes following hip and knee joint
replacement and concluded that home-based care may
be beneficial; but stressed the low quality of the current
evidence-base and surmised that further high quality
research is needed [8]. Unspecified post-operative physio-
therapy applied to a whole cohort of patients who had
undergone knee replacement did not find a significant
improvement over the control group one year following
surgery [7]. However as the majority of patients had a
good result, it was not possible to determine if targeted
intensive physiotherapy would have helped the patients
destined to have a poor outcome.
A previous UK economic analysis of a different
physiotherapy treatment than is proposed in this trial
showed no significant effects, when such physiotherapy
is applied universally to all total knee arthroplasty (TKA)
patients [9]. The analyses therefore reverted to cost-
minimisation analysis, in which assessment is made on
the basis of least costs alone. It is entirely possible that
subgroups of patients may be cost-effective to treat when
the total population is not [10]. Mitchell et al. (2005)
found the cost of physiotherapy to be small at only
£136.50 per patient (95% CI £113 to £160), as such, only a
comparatively small change in patient quality of life is
required for the treatment to fall comfortably below the
threshold of £30,000 per quality adjusted life year (QALY)
implied by NICE [11] as being cost-effective.Objectives
The primary objective of TRIO is to evaluate if early tar-
geting of post-operative physiotherapy to patients that ini-
tially perform poorly following TKA can improve patient
outcome at one year following surgery.
Secondary objectives include assessment of patient
function, patient satisfaction and the cost effectiveness
of delivering enhanced targeted physiotherapy.Methods/Design
Study design
The study is a multi-centre randomised controlled trial
comparing the effect of intensive physiotherapy with
current standard of care therapy, targeted at patients
considered to be performing poorly at six weeks follow-
ing TKR.This study makes use of the national patient Patient
Reported Outcome Measures (PROMS) programme,
whereby all providers of elective knee replacement are re-
quired to collect pre-operative data using the Oxford Knee
Score (OKS) and EuroQol 5-Dimension score (EQ-5D).
All the centres involved in this project collect routine
baseline data using these metrics. This allows us to recruit
only those poorly performing patients at the initial post-
surgical clinical review (six weeks post-operation), and not
the entire TKR population. These pre-operation data will
be accessed retrospectively for recruited patients at the
individual centres.
All patients will be made aware of the study pre-
operatively at the recruiting centres. Prior to surgery, they
will complete the routine pre-operative outcome assess-
ment questionnaires (OKS and EQ-5D) as part of the
national PROMS program and then undergo the local
standard TKR and immediate post-operative care path-
way. All patients will be routinely reviewed six weeks
post-operatively by the usual clinical teams. At this review
the OKS will again be assessed. Those patients who report
a score of 26 or less (on the 0 to 48 OKS scoring system),
which is defined as poor by the modified Kalairajah classi-
fication [12], will be approached to consent. If consent is
given and they are eligible to enter the trial, they will be
randomised to either standard care (defined in this study
as: initial physiotherapy review, six weeks of home exer-
cise prescription and final review) or an interventional
arm, where 18 sessions of structured physiotherapy will be
administered over a six week period. Six of these 18
sessions will be ‘contact sessions’ performed under the
supervision of the physiotherapist.
Focus groups run by the Arthritis Research UK
Osteoarthritis Clinical Study Group in the preparation
phase of this trial identified that the standard care
provision of physiotherapy post-arthroplasty varies
across the UK and even within local healthcare author-
ities. We therefore standardised the control arm to be
an unsupervised home exercise intervention with initial
and final physiotherapist review, which the focus group
agreed represented a frequent provision across the UK.
This approach allows us to comment on the efficacy of
‘contact’ interventional physiotherapy in addition to sim-
ple review and exercise provision and to assess the cost-
effectiveness of differing ways of providing post-operative
physiotherapy to this targeted patient group.
All trial participants will be reviewed immediately post
physiotherapy intervention (that is, at 14 weeks post-
operation) and then by postal questionnaire at six months
and one year post-operation (Figure 1). All post-operative
data collection time points are determined by the date
of surgery (not the date of trial randomisation). Use of
the national PROMS program outcome assessment tools,
in addition to their direct applicability, will allow direct
Figure 1 Trial flowchart.
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the wider TKA population.
Primary outcome measure
The OKS was selected as the primary outcome assess-
ment as it has been developed specifically to measure
the outcomes of knee replacement [13,14]. The OKS is a
patient reported outcome measure that was designed to
measure the impact of pain and functional disability on
an individual’s life [15,16]. As such, it is an extensively
validated and widely adopted outcome measure in
patients undergoing knee replacement surgery and issensitive to detect changes over time. The OKS is
also the most appropriate tool as it is the chosen
PROM for this population in the National Joint
Registry.
Secondary outcome measures
Global knee pain severity will be assessed using an 11
point (0 to 10) Visual Analogue Scale (VAS), where 0
represents no pain and 10 the worst possible pain. The
validity and sensitivity of the VAS has been well docu-
mented [17]. It has been suggested that using multiple
measurements of pain status as opposed to a single
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meaningful measurements of pain intensity [18].
Separate assessments are made of ‘worst pain’ and
‘perceived mean daily pain’ as has been specifically
recommended for use in osteoarthritis (OA) clinical
trials [19].
The Timed-get-up-and-go test (TUG) is a simple test
used to assess a person's mobility, requiring both static
and dynamic balance. It is the time that a person takes
to rise from a chair, walk three meters, turn around,
walk back to the chair, and sit down. TUG performance
has been found to decrease significantly with mobility
impairments, while residential status and physical mobil-
ity status have been determined to be significant predic-
tors of TUG performance [20]. The TUG has excellent
inter-rater and intra-rater reliability [21]. The test score
also correlates well with gait speed and scores on bal-
ance assessments.
Patient satisfaction will be assessed with a specific
patient satisfaction question. The overall satisfaction
response is thought to be primarily influenced by patient
pain, function and meeting of pre-operative expectations
[3], thus a further four additional specific sub-questions
relating to these facets of satisfaction will also be asked
to explore the effect of the trial intervention.
Health economic analysis will compare the cost-effect-
iveness over one year of providing additional physiother-
apy, as described above, against standard care for those
patients defined as performing poorly by their Oxford
Knee Score after six weeks. A cost-utility analysis (calcula-
tion of incremental costs per quality adjusted life years
(QALY) gained) will be performed from the NHS perspec-
tive in line with the preferred method by NICE [22]. The
EQ-5D questionnaire [23] and bespoke health economic
questionnaire will be used to collect these data. Resource
use estimates from the study will be combined with unit
costs taken from standard costing sources to produce
an estimate of the cost to the NHS of providing the
treatment.
Study population
Four hundred and forty patients identified at six week
post-operative clinical review and defined as performing
poorly will be recruited to the study. The planned
recruitment period is 18 months.
Inclusion criteria
1. Patients undergoing primary TKA for
osteoarthritis.
2. Defined poor outcome (OKS less than or equal to 26)
at first post-operative review (six weeks).
3. Patients are able to consent and willing to comply
with the study protocol.Exclusion criteria
1. Patients undergoing revision knee arthroplasty or
fully constrained knee arthroplasty.
2. TKR for a diagnosis other than osteoarthritis.
3. Patients unable to attend the study physiotherapy
intervention centres.
4. Procedures done purely for pain relief (such as for
patients with no walking capacity).
5. Patient’s already receiving on-going structured
post-operative exercise rehabilitation.
Recruitment and consent
Patients will be made aware of the trial at time of surgical
pre-admission. All patients attending six week post-surgical
review clinic will be screened for eligibility, and if suitable,
invited to participate in the trial. Written informed consent
will be obtained by a suitably qualified member of the re-
search team at study entry.
Randomisation procedures
Randomisation will be carried out using a bespoke web-
based randomisation protocol. Patients will be randomised
on a 1:1 ratio to either ‘standard of care physiotherapy’ or
‘enhanced physiotherapy’. Randomisation will be stratified
by centre with block allocation.
Intervention
The specific rehabilitation protocol we will employ for
TRIO is based on the current best evidence of functional
rehabilitation [24]. This incorporates four categories: (1)
range of motion, (2) strengthening (3) proprioception
and (4) balance/gait. The specific exercises the therapist
will use to achieve defined goals for each category are
outlined in detail in Table 1.
Patients in the interventional arm of the trial will
see their physiotherapist once a week for structured
rehabilitation; they will be expected to undertake a
further two sessions of specified exercise according to
the trial exercise prescription. This additional rehabilita-
tion will be directed by the physiotherapist and reviewed
at the weekly ‘contact’ session. This protocol is in marked
contrast with the ‘routine standard of care’ arm, which
consists of home-based exercises involving bending the
knee in isolation and using the weight of the limb to
strengthen the quadriceps muscle with a static knee.
The participant will be asked to perform 18 sessions
of unsupervised home exercise in this trial arm. For
the stated ‘non-contact’ physiotherapy sessions (in both
arms of the trial), the patient will be given a rehabilitation
diary to document the exercise they undertake. Extra or
additional physiotherapy will not be offered to the control
group within the trial period. The activities of both groups
Table 1 Rehabilitation protocol
Category Description Expected achievements
Range of motion • Prone knee flexion AROM • AROM of 100
• Heel props for extension PROM • Less than 1cm effusion after exercises
• Stationary bicycle/rowing machine for ROM stimulus and endurance • Able to attain full extension
• Hamstring, quadriceps & gastrocnemius /soleus stretching
• Total end range time (TERT) of 30 minutes a day until ROM
guideline attained (Aim 100°)
Strengthening • Isometric quads • Able to achieve voluntary quadriceps
control, demonstrated by SLR without lag
• Straight leg raise (if not able)
• Able to perform semi squat equal weight
bearing between limbs• Partial squats to 90°
• Supine sub-maximal leg press or equivalent (emphasis on pain
free motion and neuromuscular control vs. pure strengthening)
• Front and lateral step ups progressing from 10cm
• Resistive exercises against Theraband 90°-30° in sitting – progress
to 90°-0°
Proprioception • Balance exercises in single leg stance • Able to perform sit-to-stand unsupported
• Sit to stand • Able to perform single leg stance activities
• Balance ball
• BalanceMaster / low wobbleboard if BalanceMaster not available
• Perturbation from soft unstable surface
Balance/Gait • Braiding – alternate front and back crossover steps whilst moving
laterally – progress by increasing speed
• Able to complete multiple changes of
direction walking without support
• Tandem Walk forward and backwards
• Walk multiple change in direction on command
• Shuttle walking to increase stamina
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ceiving extra physiotherapy will be documented.
Study assessments
All the study centres involved in this project collect
routine baseline data using the OKS and EQ-5D. These
data will be accessed retrospectively for recruited patients
at the individual centres.
At the study baseline (six weeks post-operation) an
OKS will be completed and eligible patients consented
and randomised. Once consent has been obtained,Table 2 Study assessments by time point
Time point Pre-operation 6 weeks
OKS X X
EQ-5D X X
Patient demographics X
Pain score VAS X
Health economics questionnaire X
TUG
Satisfaction questionnaire
Trial baseline is at six weeks post-operation. Pre-operative data will be accessed retthe additional trial Health Economics Questionnaire
and EQ-5D questionnaire will be completed. Phy-
siotherapy pre-intervention assessment will occur two
weeks following this (and TUG test performed). Fol-
lowing either study intervention, all patients will
have a second (post-intervention) physiotherapy review
(OKS, TUG, EQ-5D and Health Economics Question-
naire). At six months and one year post-operation,
the OKS, EQ-5D, Health Economics and Satisfaction
questions will be assessed by postal questionnaire
(Table 2).8 weeks 14 weeks 6 months 1 year
X X X
X X X
X X X
X X X
X X
X X
rospectively. Assessment timeframes are calculated from the date of surgery.
Table 3 Power calculation
Difference Size Power
3 150 80%
3 200 90%
Two-sample t-test, alpha = 0.05 (two-sided), assumed SD = 9.2.
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As the study is a non-Clinical Trial of an Investigational
Medicinal Product (CTIMP) with an intervention of
additional physiotherapy, there is not deemed to be a
significant risk to patient safety. In the case of adverse
events, participants will be advised to seek medical
advice through their general practitioner. Specific adverse
events such as treatment withdrawals and missed treat-
ments due to pain will be collected through the study case
report form. Patient reported outcomes will measure knee
pain using a Visual Analogue Scale (VAS) and global
health state via the EQ-5D.
Sample size calculation
The sample size for TRIO is 400 patients (200 per arm).
This was determined from previous research. The power
calculation (Table 3) is based on the accepted change in
the OKS that is considered clinically significant and of
interest when comparing interventions (3 points) [16].
Typical one year change scores for the OKS are 16 points
with a reported standard deviation of 9.2 [3,4].
A large prospective cohort is required to achieve the
desired numbers of poorly functioning knees; therefore
the study will recruit from multiple major centres. Based
on reported poor outcome rates of approximately 20%,
and allowing for a potential of up to 20% of eligible pa-
tients being unwilling to be randomised, we aim to screen
2,750 patients prospectively at the six-week post-surgical
review to identify 550 eligible, poorly functioning patients
and to achieve recruitment (randomisation) of 440. Allow-
ing for a further 10% loss to follow-up in the RCT will
yield the 400 patients we require.
Statistical analysis
The difference in mean OKS between the groups at
one year will be estimated using analysis of covariance
(ANCOVA) to adjust for baseline OKS at randomisation
(that is, at six weeks). The results will be presented as an
adjusted mean difference with its corresponding 95%
confidence interval. The principal analysis will be on an
intention to treat basis where participants will be ana-
lysed according to the allocated group using all available
data. Additional summary statistics will also be pre-
sented for change in OKS from pre-operative values.
Health economic analysis will compare the cost-effectiveness
(over one year) of providing targeted additional physiotherapy
to those patients defined as performing poorly after six weeksagainst standard care. A cost-utility analysis (calculation of
incremental costs per quality adjusted life year (QALY)
gained) will be performed from the NHS perspective in line
with the preferred method by NICE [22]. Resource use esti-
mates from the study will be combined with unit costs
taken from standard costing sources to produce an estimate
of the cost to the NHS of providing the treatment. Health
benefits in terms of QALYs will be derived from the stand-
ard UK tariff for the EQ-5D [25]. Estimates of NHS cost
and QALYs will then be combined to produce an incre-
mental cost-effectiveness ratio. This ratio will be presented
using probabilistic sensitivity analysis [26] with determinis-
tic analysis used on key modelling assumptions.
Ethics
TRIO has received ethical approval from the National
Research Ethics Service, South East Scotland Research
Ethics Committee 01 in April 2013 (REC reference: 13/
SS/0051).
Trial status
Recruitment to TRIO commenced in September 2013 and
is on-going at the time of manuscript submission. The
expected time of recruitment completion is March 2015.
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